8细胞期卵裂球活检用于植入前遗传学诊断的最佳时机
该回顾性队列研究比较了8细胞期不同时间象限(Q1-Q4)进行卵裂球活检的胚胎与未活检对照及已知植入胚胎的后续发育时序,发现Q4(15-20小时)活检的胚胎发育动态最接近对照和已植入胚胎,提示Q4可能是最佳活检时机。
要点
- 8细胞期Q4(15-20 h post-t8)活检胚胎的后续发育事件时序与对照胚胎一致。
- Q1-Q3活检胚胎在活检后首次卵裂、致密化及囊胚起始均较已植入活检胚胎显著延迟。
- Q4活检胚胎仅在囊胚起始阶段较已植入活检胚胎延迟,其余动态相似。
核心结论
- 在8细胞期最后四分之一(Q4)进行卵裂球活检对胚胎后续发育影响较小,其植入潜力优于Q1-Q3活检的胚胎。
研究设计与样本
- 回顾性队列研究,研究组为2012-2014年间在本单位因单基因病或染色体易位行PGD的195枚8细胞期活检胚胎,对照组为同期未活检的115枚ICSI胚胎,均培养至移植。
主要发现
- Q3(8细胞期后10-15小时)活检胚胎在活检后首次卵裂、致密化(tM)和囊胚起始(tSB)三个后续发育事件均延迟。
- Q1、Q2或Q4活检胚胎的上述事件发生时间与对照组完全一致。
- Q1、Q2或Q3活检胚胎从t8起以及tM和tSB均较已植入的活检胚胎显著延迟。
- Q4活检胚胎在t8和tM的动态与已植入活检胚胎相似,仅在tSB阶段出现延迟。
关键数值与推荐
- 8细胞期分为四个象限:t8后第一个5小时(Q1)、5-10小时(Q2)、10-15小时(Q3)、15-20小时(Q4)。
- 非活检对照胚胎分为四个等效象限。
- 比较的发育事件包括活检后首次卵裂时间、致密化时间(tM)和囊胚起始时间(tSB)。
- 与56枚已知植入数据的PGD活检胚胎(PGD-KID-positive)进行比较。
临床怎么用
- 作者认为,在胚胎生长的关键时期即8细胞期Q4进行卵裂球活检,对后续发育的危害可能较小。
- 作者指出延时显微成像对确定卵裂球活检的最佳时机具有附加价值。
局限性
- 这是一项回顾性研究,仅限于IVF实验室常规执行的活检时机。
- 需要进行前瞻性研究,在 desired timing 进行活检,以区分活检本身的影响和胚胎卵裂率的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the optimal timing for blastomere biopsy during the 8-cell stage, at which embryos will have the best implantation potential? SUMMARY ANSWER: Fast-cleaving embryos that are biopsied during the last quarter (Q4) of the 8-cell stage and are less affected by the biopsy procedure, and their implantation potential is better than that of embryos biopsied earlier during the 8-cell stage (Q1-Q3). WHAT IS KNOWN ALREADY: Blastomer biopsy from cleavage-stage embryos is usually performed on the morning of Day 3 when the embryos are at the 6- to 8-cell stage and is still the preferred biopsy method for preimplantation genetic diagnosis (PGD) for monogentic disorders or chromosomal translocations. Human embryos usually remain at the 8-cell stage for a relatively long 'arrest phase' in which cells grow, duplicate their DNA and synthesize various proteins in preparation for the subsequent division. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study. The study group (195 embryos) included all 8-cell stage embryos that underwent blastomere biopsy for PGD for monogenetic disorders and chromosomal translocations in our unit between 2012-2014 and cultured in the EmbryoScope until transfer. The control group (115 embryos) included all embryos that underwent intracytoplasmic sperm injection without a biopsy during the same period. PARTICIPANTS/MATERIALS, SETTING, METHODS: The 8-cell stage was divided into four quarters: the first 5 h post-t8 (Q1), 5-10 h post-t8 (Q2), 10-15 h post-t8 (Q3) and at 15-20 h post-t8 (Q4). Non-biopsied control embryos were divided into four equivalent quarters. Embryos were evaluated for timing of developmental events following biopsy including timing of first cleavge after biopsy, timing of comapction (tM) and start of blastulation (tSB). Timing of these events were compared between PGD and control embryos, as well as with 56 PGD implanted embryos with Known Implantation Data (PGD-KID-positive embryos). MAIN RESULTS AND THE ROLE OF CHANCE: Embryos that were biopsied during Q3 (10-15 h from entry into 8-cell stage) were delayed in all three subsequent developmental events, including first cleavage after biopsy, compaction and start of blastulation. In contrast, these events occurred exactly at the same time as in the control group, in embryos that were biopsied during Q1, Q2 or Q4 of the 8-cell stage. The results show also that embryos that were biopsied during Q1, Q2 or Q3 of the 8-cell stage demonstrated a significant delay from the biopsied implanted embryos already in t8 as well as in tM and tSB. However, embryos that were biopsied during Q4 demonstrated dynamics similar to those of the biopsied implanted embryos in t8 and tM, and a delay was noticed only in the last stage of tSB. LIMITATIONS, REASONS FOR CAUTION: This is a retrospective study that is limited to the timing of biopsy that is routinely performed in the IVF lab. A prospective study in which biopsy will be performed at a desired timing is needed in order to differ between the effect of biopsy itself and the cleavage rate of the embryo. WIDER IMPLICATIONS OF THE FINDINGS: Our findings showed that blastomere biopsy can be less harmful to further development if it is carried out during a critical period of embryonic growth, i.e during Q4 of the 8-cell stage. They also demonstrated the added value of time-lapse microscopy for determining the optimal timing for blastomere biopsy. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the routine budget of our IVF unit. TRIAL REGISTRATION NUMBER: N/A.
引用
- Kalma Y, Bar-El L, Asaf-Tisser S, et al. Optimal timing for blastomere biopsy of 8-cell embryos for preimplantation genetic diagnosis. Hum Reprod. 2018. PMID: 29165686. doi:10.1093/humrep/dex343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。